How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any additional equality or health inequalities issues we should consider?
  • Question on Consultation

    Has all of the relevant evidence been taken into account?
  • Question on Document

    Are there any other relevant ongoing studies that address the evidence gaps?

6 Implementation considerations

The following considerations around implementing the evidence generation process have been identified through working with system partners:

Equalities

  • It was noted that the NHS has regional variation in access to diagnostic spirometry. The technology may increase the number of primary care settings and community diagnostic centres that are able to offer spirometry as part of their services, addressing this variation.

  • The company should collect evidence from important subgroups who may benefit more from the technologies and for whom access to spirometry is limited or lacking all together. These are subgroups such as:

    • people who are less familiar with using digital technologies or have limited access to equipment or the internet

    • people living the most deprived areas

    • neurodivergent people

    • people with learning disabilities

    • people with visual, hearing or cognitive impairments

    • people who have problems with manual dexterity

    • people who have difficulties reading, writing or understanding health-related information (including people who cannot read English).

Evidence generation

  • Diagnosis of asthma and COPD in addition to patient history is needed to access necessary treatment from the NHS. The company should consider testing the technology at varied points in the NHS care pathway to determine the point to enhance early diagnosis.

ISBN: [to be added at publication]